TRXC News and Press, TransEnterix Inc. From 05/28/19

TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced that it has received Japanese regulatory approval for the Senhance™ Surgical System. “Reg...

SIMPLIFYING RECENT INNOVATON ANNOUNCEMENTS AT HRS IN TERMS OF REVENUE AND PROFITABLITY; STRONG POTENTIAL OUTLOOK WITH OVER $60 MILLION IN SALES AND LARGE PROFITS FROM JUST EXISTING CUSTOMER BASE Stereotaxis is a global pioneer and leader of robotics for endovascular surgery with a fantasti...

CymaBay Therapeutics (NASDAQ: CBAY ) initiated with Buy rating and $21 (70% upside) price target at Citigroup. Shares up  1%  premarket. More news on: CymaBay Therapeutics, Inc., MannKind Corporation, Pieris Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, , ...

Gainers:  Charles & Colvard (NASDAQ: CTHR ) +34% . Buckeye Partners (NYSE: BPL ) +28% . Cardlytics (NASDAQ: CDLX ) +26% . G1 Therapeutics (NASDAQ: GTHX ) +24% . Westport Fuel Systems (NASDAQ: WPRT ) +21% . Cool Holdings (NASDAQ: AWSM ) +22% . Guardant Health (NASDAQ: GH ) +...

Puma Biotechnology (NASDAQ: PBYI )  -35%  on Q1 earnings . More news on: Puma Biotechnology, Inc., TransEnterix, Inc., Verastem, Inc., Stocks on the move, Read more ...

TransEnterix, Inc. (TRXC) Q1 2019 Results Conference Call May 09, 2019 04:30 PM ET Company Participants Mark Klausner - Investor Relations Todd Pope - President and Chief Executive Officer Joe Slattery - Executive Vice President and Chief Financial Officer Conference Call Part...

"We were disappointed with our results in the first quarter," says CEO Todd Pope, though he notes "solid progress" towards the expansion of the company's global sales infrastructure and the development of the U.S. installed base. More news on: TransEnterix, Inc., Healthcare stocks news, St...

TransEnterix (NYSEMKT: TRXC ): Q1 Non-GAAP EPS of -$0.09 misses by $0.01 ; GAAP EPS of -$0.10 misses by $0.01 . Revenue of $2.18M (-54.3% Y/Y) misses by $3.62M . Shares -15.2% . Press Release More news on: TransEnterix, Inc., Earnings news and commentary, Healthcare stocks news...

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the first quarter of 2019. Recent Highlights Total...

AAXN , AGO , AIRG , AL , ALRM , ALTR , AMBC , AMBR , AMPH , AQN , ASYS , BGNE , BKNG , CABO , CARG , CISN , CORT , CTRL , CUTR , DBX , EFX , ELY , EQH , FGEN , FLY , FSCT , GH , GLOB , GPRO , GSBD , ICUI , JAG , MAIN , MAXR , MTD , MTW , NDLS , NTR , N...